The University of Chicago Header Logo

Connection

Seleeke Flingai to Tumor Burden

Back to Details
This is a "connection" page, showing publications Seleeke Flingai has written about Tumor Burden.
Seleeke Flingai
Connection Strength
0.027
Tumor Burden
  1. A human ErbB2-specific T-cell receptor confers potent antitumor effector functions in genetically engineered primary cytotoxic lymphocytes. Hum Gene Ther. 2014 Aug; 25(8):730-9.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.